
Irodac CT 150mg/12.5mg Tablet
Marketer
Smithways Oncology Private Limited
Salt Composition
Irbesartan (150mg) + Chlorthalidone (12.5mg)
Overview Irodac CT 150mg/12.5mg Tablet
Hypertensive patients may benefit from the combined medication, TensoCare 150mg/12.5mg tablets, to manage elevated blood pressure. This medication lowers blood pressure by dilating and relaxing blood vessels, also promoting the excretion of excess fluid and electrolytes. TensoCare 150mg/12.5mg tablets can be administered with or without food; consistent daily dosing at the same time maximizes efficacy. Increased urination is a potential side effect; therefore, daytime administration is recommended. Missed doses should be taken immediately upon recollection. Complete the prescribed course of treatment, even with symptom improvement; abrupt cessation should be avoided without physician consultation. Common, typically mild, side effects include dizziness, lightheadedness, and gastrointestinal upset. Persistent or bothersome side effects warrant medical attention. Regular monitoring of blood pressure, renal function, and blood glucose may be required. Pre-existing liver or kidney conditions, pregnancy, pregnancy planning, breastfeeding, and all other medications being taken must be disclosed to your doctor before commencing treatment due to potential interactions.
Uses of Irodac CT 150mg/12.5mg Tablet
Managing Elevated Blood Pressure
Major Benefits of Irodac CT 150mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The Irodac CT 150mg/12.5mg Tablet should be swallowed whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistency in timing is recommended.
Common Side effects of Irodac CT 150mg/12.5mg Tablet:
- Dizziness
- Lightheadedness
- Upset stomach
How to use Irodac CT 150mg/12.5mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Irodac CT 150mg/12.5mg Tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, however, consistent timing is recommended.
How Irodac CT 150mg/12.5mg Tablet works:
Irodac CT 150mg/12.5mg tablets contain irbesartan and chlorthalidone, working synergistically to manage hypertension. Irbesartan, an angiotensin II receptor antagonist (ARB), reduces blood pressure by inhibiting vasoconstriction, thus improving blood flow and cardiac function. Chlorthalidone, a diuretic, lowers blood pressure by promoting fluid excretion and electrolyte balance, additionally contributing to vasodilation and enhanced circulation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Irodac CT 150mg/12.5mg Tablet lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Irodac CT 150mg/12.5mg tablets in pregnancy are lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Irodac CT 150mg/12.5mg Tablet with breastfeeding is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Irodac CT 150mg/12.5mg Tablet on driving ability is undetermined. Refrain from operating a vehicle if you exhibit symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Irodac CT 150mg/12.5mg tablets cautiously. Dosage modification may be necessary; physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding the use of Irodac CT 150mg/12.5mg tablets in individuals with hepatic impairment is scarce. Seek medical advice.
What if you forget to take Irodac CT 150mg/12.5mg Tablet :
NA
Facts to Know About Irodac CT 150mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | HEART |
